Hepatitis B and D viruses replication interference: Influence of hepatitis B genotype

Table 2 Epidemiological and clinical profiles of patients

	Age1	Gender	Precedence	Mode of	Duration of	HBV Genotype2	Previous	Time without Treatment3 (mo)	Follow-up (mo)	Sampling
				transmission	infection (yr)		treatment
Pat #1	43	Male	Western Europe	Horizontal	20	Undetermined	IFN	84	74	8
Pat #2	30	Male	Equatorial Ginnea	Unknown	Unknown	A	No		5	4
Pat #3	41	Male	Equatorial Ginnea	Unknown	Unknown	E	No		2	3
Pat #4	43	Male	Eastern Europe	Unknown	Unknown	A	No		5	3
Pat #5	45	Male	Western Europe	IVD	Unknown	A	No		4	4
Pat #6	38	Female	Western Europe	Horizontal	20	D	IFN	36	94	10
Pat #7	35	Female	Western Europe	Horizontal	25	E	IFN	60	89	13
Pat #8	55	Female	Western Europe	Unknown	Unknown	D	No		17	3
Pat #9	37	Male	Equatorial Ginnea	IVD	22	A	IFN/ADV	8	77	12
Pat #10	31	Female	Western Europe	Horizontal	20	D	IFN	12	78	12
Pat #11	46	Male	Western Europe	IVD	25	A	No		53	4
Pat #12	42	Male	Western Europe	Unknown	26	D	No		93	13
Pat #13	45	Male	Western Europe	Unknown	Unknown	A	No		42	3
Pat #14	39	Male	Western Europe	IVD	20	D	No		41	6
Pat #15	53	Male	Western Europe	IVD	25	D	No		89	14
Pat #16	38	Female	Equatorial Ginnea	Unknown	Unknown	E	No		9	5

¹Data of age are referred to the first sample analyzed of each patient;

²HBV genotype data correspond to the LiPA/PCR-sequencing assays;

³Time interval between the end of the previous treatment and the sampling of the first sera included in this study. No statistical differences in the route of infection, duration of infection, or previous antiviral treatment were found between patients infected with the different HBV genotypes. HBV: Hepatitis B virus; IFN: Interferon; ADV: Adefovir; IVD: Intra venous drug user.